Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Benn

Showing results (51-60 of 87) with videos related to

Pageof 9
Sort By:
Cancer|July 7, 2005
Early growth response gene 1 (EGR1) is deleted in estrogen receptor-negative human breast carcinomaKaryn Ronski, Melinda Sanders, Joseph A Burleson, et al.
Plos One|July 10, 2015
An Economic Analysis of Cell-Free DNA Non-Invasive Prenatal Testing in the US General Pregnancy PopulationPeter Benn, Kirsten J Curnow, Steven Chapman, et al.
Prenatal Diagnosis|April 25, 2006
Three-stage contingent screening for Down syndromeDave Wright, Ian Bradbury, Howard Cuckle, et al.
Prenatal Diagnosis|May 16, 2022
Non-invasive prenatal screening for fetal triploidy using single nucleotide polymorphism-based testing: Differential diagnosis and clinical management in cases showing an extra haplotypeValerie Kantor, Russ Jelsema, Wenbo Xu, et al.
Acta Haematologica|March 25, 2011
Treatment of synchronous mantle cell lymphoma and small lymphocytic lymphoma with bendamustine and rituximabTaxiarchis V Kourelis, Brad S Kahl, Peter Benn, et al.
Circulation. Genomic and Precision Medicine|March 20, 2024
Reproductive Carrier Screening: Identifying Families at Risk for Familial Hypercholesterolemia in the United StatesVivienne Souter, Emily Becraft, Samantha Brummitt, et al.
Taiwanese Journal of Obstetrics & Gynecology|January 15, 2019
Screening for 22q11.2 deletion syndrome by two non-invasive prenatal testing methodologies: A case with discordant resultsLiang-Ming Lo, Chii-Shinn Shiau, Kuang-Chao Chen, et al.
Prenatal Diagnosis|July 30, 2011
Comparison of combined, stepwise sequential, contingent, and integrated screening in 7292 high-risk pregnant womenPaolo Guanciali-Franchi, Irene Iezzi, Chiara Palka, et al.
Journal of Genetic Counseling|May 3, 2025
Carrier screening for Alport syndrome: The clinical importance of heterozygosity for pathogenic or likely pathogenetic variantsVivienne Souter, Lisa Johnson, Emily Becraft, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|October 22, 2005
Variation of fetal nasal bone length in second-trimester fetuses according to race and ethnicityCarolyn M Zelop, Elizabeth Milewski, Kimberly Brault, et al.
Pageof 9

Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
Cancer|July 7, 2005
Early growth response gene 1 (EGR1) is deleted in estrogen receptor-negative human breast carcinomaKaryn Ronski, Melinda Sanders, Joseph A Burleson, et al.
Plos One|July 10, 2015
An Economic Analysis of Cell-Free DNA Non-Invasive Prenatal Testing in the US General Pregnancy PopulationPeter Benn, Kirsten J Curnow, Steven Chapman, et al.
Prenatal Diagnosis|April 25, 2006
Three-stage contingent screening for Down syndromeDave Wright, Ian Bradbury, Howard Cuckle, et al.
Prenatal Diagnosis|May 16, 2022
Non-invasive prenatal screening for fetal triploidy using single nucleotide polymorphism-based testing: Differential diagnosis and clinical management in cases showing an extra haplotypeValerie Kantor, Russ Jelsema, Wenbo Xu, et al.
Acta Haematologica|March 25, 2011
Treatment of synchronous mantle cell lymphoma and small lymphocytic lymphoma with bendamustine and rituximabTaxiarchis V Kourelis, Brad S Kahl, Peter Benn, et al.
Circulation. Genomic and Precision Medicine|March 20, 2024
Reproductive Carrier Screening: Identifying Families at Risk for Familial Hypercholesterolemia in the United StatesVivienne Souter, Emily Becraft, Samantha Brummitt, et al.
Taiwanese Journal of Obstetrics & Gynecology|January 15, 2019
Screening for 22q11.2 deletion syndrome by two non-invasive prenatal testing methodologies: A case with discordant resultsLiang-Ming Lo, Chii-Shinn Shiau, Kuang-Chao Chen, et al.
Prenatal Diagnosis|July 30, 2011
Comparison of combined, stepwise sequential, contingent, and integrated screening in 7292 high-risk pregnant womenPaolo Guanciali-Franchi, Irene Iezzi, Chiara Palka, et al.
Journal of Genetic Counseling|May 3, 2025
Carrier screening for Alport syndrome: The clinical importance of heterozygosity for pathogenic or likely pathogenetic variantsVivienne Souter, Lisa Johnson, Emily Becraft, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|October 22, 2005
Variation of fetal nasal bone length in second-trimester fetuses according to race and ethnicityCarolyn M Zelop, Elizabeth Milewski, Kimberly Brault, et al.
Pageof 9